Full Press Release Details
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement.
LXRX
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
Key Takeaway: Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
Price reaction · baseline $3.3 (2023-05-31 close) · hit after-hours · 2 other LXRX headline(s) in the window, move may be shared
day 0 close
-17.9%
day 1
-16.8%
day 3 · peak
-19.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus